Your browser doesn't support javascript.
loading
Advantages of evaluating γH2AX induction in non-clinical drug development.
Motoyama, Shigeki; Takeiri, Akira; Tanaka, Kenji; Harada, Asako; Matsuzaki, Kaori; Taketo, Junko; Matsuo, Saori; Fujii, Etsuko; Mishima, Masayuki.
Afiliação
  • Motoyama S; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Takeiri A; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Tanaka K; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Harada A; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Matsuzaki K; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Taketo J; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Matsuo S; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Fujii E; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
  • Mishima M; Research Division, Chugai Pharmaceutical Co., Ltd, Gotemba, Shizuoka Japan.
Genes Environ ; 40: 10, 2018.
Article em En | MEDLINE | ID: mdl-29785231
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genes Environ Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Genes Environ Ano de publicação: 2018 Tipo de documento: Article